![]() | ![]() |
Formats:
|
||||||||
Copyright © 2006, Can Fam Physician Knee joint injections and aspirations The triangle technique Scientific documentation on the optimal injection procedure for knee joint injection is
sparse.1 In the absence of a knee effusion,
placing the needle precisely into the intraarticular space presents a challenge to
clinicians.2 One study showed that about one
third of knee injections were extraarticular; another showed that about 90% were
extraarticular.1 Osteoarthritis is one of the most common and costly chronic medical conditions. Most
current therapies are directed toward minimizing pain and swelling, maintaining joint
mobility, and reducing associated disability.2 To
achieve the maximum potential benefit, hyaluronan-based preparations should be delivered
directly into the intraarticular space, not into the anterior fat pad or the subsynovial
tissue layers.2 The technique I describe was discovered by doing 5 to 10 of these injections a month for
2 to 3 years, by getting feedback from patients and colleagues, and by drawing on my own
personal clinical experience. To verify that the procedure had never been done, I searched MEDLINE, EMBASE, and PubMed
from 1966 to 2004 using the MeSH words “knee injection,” “aspiration,” “lateral
approach,” “mid-patella,” “knee flexion,” and “triangle.” No studies on the technique
were found. Combining “injections” and “mid-patella,” however, did reveal 1 article
mentioning a lateral midpatella approach with the knee extended.2 Indications for knee aspiration include unexplained effusion, possible septic arthritis,
and relief of discomfort caused by an effusion.3
Indications for injection include delivery of corticosteroids for advanced
osteoarthritis and other noninfectious inflammatory arthritides, such as gout, calcium
pyrophosphate deposition disease, or delivery of viscosupplementation.
Viscosupplementation and corticosteroid therapies are not used concomitantly.3 Contraindications to injections are superimposed septic arthritis in rheumatoid arthritis
patients, acutely inflamed joints, effusion not detected by clinical examination but
detected by aspiration before injections,4 skin
lesions, and risk of infection. Materials The size of syringe or needle depends on its application:
You will also require 2 mL of 2% lidocaine for local anesthetic, 40 mg/mL or 80 mg/mL
of methylprednisolone, a marker, and alcohol swabs or iodine. Technique The patient should be sitting with the knee flexed at 90˚. Locate the apex of the
patella by palpation. This is also the apex of the triangle. Draw a line from the
apex to the lateral upper pole of the patella and another line from the apex to the
medial upper pole of the patella. Join these lines, with the base of the triangle
forming the upper border of the patella. This position with the knee flexed is used
for injecting or aspirating the knee. On the lateral side of the isosceles triangle find the midpoint. Mark the midpoint
with ink. This is where the needle entry for injection will be (approximately
midpatella). Mix 1 mL of either 40 mg/mL or 80 mg/mL of methylprednisolone (depending on required
dosage) with 2 mL of lidocaine. Draw up the 2 mL of lidocaine first and then the
methylprednisolone as it mixes better that way. Clean the area with alcohol or iodine. Insert the needle into the space between the
patella and femur parallel to the middle facet of the patella using the ink spot as
the point of entry. Angle the needle to the centre of the patella and inject the
mixture into the space between the patella and the femur (Figure 1
In obese patients landmarks are sometimes difficult to palpate. When this is the
case, locate the apex of the patella by palpation. Draw a line from this apex to the
outermost medial and lateral aspects of the knee. Join all these lines to form an
upside down isosceles triangle and proceed. For obese patients, use a 1.5-inch 25-gauge needle, and for thin patients, use a
1-inch 25-gauge needle. The distance measured from the edge of the skin to the
articular surface of the femoral condyle can range from 4.5 to 5.5 cm.2 The additional 1 cm will help the needle to
clear the intraarticular fat pad and reach the intraarticular space.2 The lidocaine-methylprednisolone mixture passes into the joint capsule and
anesthetizes the articular surfaces of the knee joint; this effect gives patients
immediate relief and they feel like moving the joint instantaneously. Most current
methods of assessing the accuracy of needle placement, such as imaging or injecting
air or contrast material into the knee joint, are too invasive for routine clinical
application. My accuracy rate of 85 out of 95 placements was determined by
questioning patients and assessing the following symptoms and signs: pain, range of
movement, tenderness, willingness to repeat or repeating the procedure in 4 to 6
months, and improvement in social and occupational functioning. These parameters
were assessed at the time of the procedure, 2 to 4 weeks later, and 4 to 6 months
after that and noted in patients’ charts. I still see some side effects of the procedure, such as infection, flushing, and
hypotension, as described in the literature. Aspirating and injecting knee joints
provides family physicians with a wealth of knowledge about knee pathology as well
as about therapeutic measures to relieve pain and suffering. One of the main reasons
these techniques are not widely used in family practice is that some physicians are
anxious about injecting needles into joint spaces, and some patients think that
because needles are involved, the procedure must be painful. When inserting the needle, try not to poke around too much as it might be
uncomfortable for patients. Entry should be deliberate and smooth at an angle of
between 15˚ and 20˚. If the needle meets an obstruction, pull back slightly and aim
anteriorly. I use only the lateral midpatellar knee-flexed position for knee
injections. Some physicians infiltrate the skin with local anesthetic before
injecting into the intraarticular space. I do not use local anesthetic in this way.
The only cost to patients is the vial of methylprednisolone and pharmacy fees. Other techniques Many rheumatologists prefer the medial approach with knee extended and patient lying
down because the lateral patellofemoral cleft is narrower, and the joint capsule is
tougher laterally than medially. These conditions did not hinder my lateral
approach. The anterior approach preferred by some physicians might involve greater
risk of meniscal injury caused by the needle.3 Some physicians use anterolateral, anteromedial, and upper-lateral approaches. Some
use a lateral midpatella approach with the knee extended. In this technique, the
physician uses his or her free hand to manually evert and move the patella laterally
so the needle can enter the knee space. I find this method cumbersome and
time-consuming. Conclusion My experience with the triangle technique has been rewarding. My accuracy rate is
about 90% and in keeping with an accuracy rate of 93% reported by some authors using
other techniques.2 Biography
References 1. Weitoft T, Uddenfeldt P. Importance of synovial fluid aspiration when injecting
intra-articular corticosteroids. Ann Rheum Dis. 2000;59:233–235. [PubMed] 2. Jackson DW, Evans NA, Thomas BM. Accuracy of needle placement into the intra-articular space of
the knee. J Bone Joint Surg Am. 2002;84-A(9):1522–1527. [PubMed] 3. Cardone DA, Tallia AF. Diagnostic and therapeutic injection of the hip and knee. Am Fam Physician. 2003;67(10):2147–2152. [PubMed] 4. Bliddal H. Placement of intra-articular injections verified by mini
air-arthrography. Ann Rheum Dis. 1999;58:641–643. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||
Ann Rheum Dis. 2000 Mar; 59(3):233-5.
[Ann Rheum Dis. 2000]J Bone Joint Surg Am. 2002 Sep; 84-A(9):1522-7.
[J Bone Joint Surg Am. 2002]J Bone Joint Surg Am. 2002 Sep; 84-A(9):1522-7.
[J Bone Joint Surg Am. 2002]J Bone Joint Surg Am. 2002 Sep; 84-A(9):1522-7.
[J Bone Joint Surg Am. 2002]Am Fam Physician. 2003 May 15; 67(10):2147-52.
[Am Fam Physician. 2003]Ann Rheum Dis. 1999 Oct; 58(10):641-3.
[Ann Rheum Dis. 1999]J Bone Joint Surg Am. 2002 Sep; 84-A(9):1522-7.
[J Bone Joint Surg Am. 2002]Am Fam Physician. 2003 May 15; 67(10):2147-52.
[Am Fam Physician. 2003]J Bone Joint Surg Am. 2002 Sep; 84-A(9):1522-7.
[J Bone Joint Surg Am. 2002]